Drinking Water Diagnostics and CRADA with the U.S. Environmental Protection Agency
NanoLogix has a Cooperative Research and Development Agreement (CRADA #608-10,July 9,2010) with the U.S. Environmental Protection Agency to design a rapid diagnostic method to detect bacterial threats, including E. coli and Cryptosporidium in drinking and source water. Scientists from the EPA and NanoLogix are using the company's rapid detection technology as a foundation for the new process, with the goal of significantly reducing the test times over conventional methods.
The FTTA (Federal Technology Transfer Act) Agreement is between NanoLogix, Incorporated and the National Exposure Research Laboratory (NERL). Other than what is stated in the EPA internal press release linked below,details of the CRADA are classified and exempt from the FOIA for a period of five years from the initial contract date.
More information can be found at the following link: U.S. EPA MCREAD News page. This is an archived link temporarily available on the NanoLogix website until the EPA website design team restores the EPA site archive for MCEARD News.